The tumour necrosis factor-related apoptosis-inducing ligand-osteoprotegerin system in limited systemic sclerosis: a new disease marker?
Castellino
Gabriella
G
Department of Clinical and Experimental Medicine, Azienda Ospedaliero-Universitaria Sant' Anna, University of Ferrara, Corso della Giovecca, 203, 44100 Ferrara, Italy. gabriella_castellino@yahoo.it
Corallini
Federica
F
Bortoluzzi
Alessandra
A
La Corte
Renato
R
Lo Monaco
Andrea
A
Secchiero
Paola
P
Zauli
Giorgio
G
Trotta
Francesco
F
D000328:Adult; D000368:Aged; D017209:Apoptosis; D051033:Apoptosis Inducing Factor; D015415:Biomarkers / Q000378:metabolism; D016022:Case-Control Studies; D042783:Endothelial Cells / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D053244:Osteoprotegerin / Q000378:metabolism*; D053245:RANK Ligand / Q000378:metabolism*; D045745:Scleroderma, Limited / Q000378:metabolism*; D013223:Statistics as Topic; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000378:metabolism*; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*; D044465:White People
D051033:Apoptosis Inducing Factor; D015415:Biomarkers; D053244:Osteoprotegerin; D053245:RANK Ligand; D053221:TNF-Related Apoptosis-Inducing Ligand; D014409:Tumor Necrosis Factor-alpha